Omeros Share Price

Omeros Share Price

NASDAQ: OMER | Small Cap | Healthcare
$13.21
-$0.79 (-5.61%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Omeros Stock Performance

Open
$13.77
Prev. Close
$14.00
Circuit Range
N/A
Day Range
$13.09 - $13.86
Year Range
$6.86 - $21.23
Volume
72,858
Average Traded
$13.41

Omeros Share Price Today

As of 21 November 2026, Omeros Corporation's share price is $13.21. The stock opened at $13.77, compared to its previous close of $14.00. During today's trading session, Omeros Corporation's share price traded between $13.09 and $13.86, with an average price of $13.47. Over the past 52 weeks, the stock has recorded a high of $21.23 and a low of $6.86. In terms of performance, Omeros Corporation's share price has risen by 19.76% over the last six months and is up 36.66% on a year-on-year basis.

Omeros Share Price Chart

Line chart of the Omeros price trend over the selected period. The price fell overall, ranging from 13.09 to 13.84, ending at 13.21.
$13.09$13.86
L
Show Current Price
H

Omeros Stock Fundamentals & Key Indicators

Market Cap
$839.29M
PE Ratio (TTM)
10.60
Dividend Yield
0.00%
EPS (TTM)
$1.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-109.35%
Profit Margin
N/A
Debt to Equity
-0.35
Quarterly Earnings Growth YoY
-166.35%

Omeros Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$9.89$28.53$35.93
Net Profit$86.45$56.06$13.23-$57.36
Net Profit MarginN/A566.84%46.37%-159.64%
Income ChangeN/A-35.15%-76.40%-533.56%

Omeros Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit$47.42-$117.81-$156.82-$3.35
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-348.44%-33.11%97.86%

Omeros Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets109.97142.96160.37147.73
Current Assets215.67134.12217.9443.24
Total Assets325.63277.08378.27590.97
Non Current Liabilities368.8380.16349.94368.9
Current Liabilities78.0679.5353.32136.38
Total Liabilities446.86459.69403.25505.29
Shareholders' Equity-121.23-182.61-24.9885.68

Omeros Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-116.09-148.874.73-86.48
Investing164.5282.2227.45-127.56
Financing-42.1762.88-106.08124.25

About Omeros

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Omeros Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$18.50
$13.20
-28.44%
Oct 2026
$18.86
$18.44
-3.33%
Sep 2026
$18.67
$19.07
-0.91%
Aug 2026
$12.29
$19.25
+62.31%
Jul 2026
$9.56
$11.86
+24.58%
Jun 2026
$10.90
$9.52
-13.73%
May 2026
$14.69
$11.04
-24.31%
Apr 2026
$11.39
$14.58
+37.94%
Mar 2026
$11.99
$10.57
-12.32%
Feb 2026
$11.56
$12.05
+2.95%
Jan 2026
$17.26
$11.71
-31.84%
Dec 2025
$9.82
$17.18
+77.66%

Omeros Share Price FAQs